To the full analysis
UnitedHealth Group stock: growth
UNHUnitedHealth Group reported $447.57B in revenue for fiscal 2025, up 11.8% on the prior year, up 11.7% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
10.1%
per year from 2006 to 2025, per share 12.4%
Earnings (Annual rate)
5.8%
per year from 2006 to 2025, per share 8%
Free cash flow (Annual rate)
5.5%
per year from 2006 to 2025, per share 7.7%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 11.7% | 11.0% | 10.1% |
| Revenue per share | 12.6% | 11.6% | 12.4% |
| Earnings | −4.8% | 7.6% | 5.8% |
| Earnings per share | −4.1% | 8.0% | 8.0% |
| Free cash flow | −4.4% | 7.0% | 5.5% |
| Free cash flow per share | −3.6% | 7.5% | 7.7% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $71.54B | $4.16B | $5.8B |
| 2007 | $75.43B | $4.65B | $5.01B |
| 2008 | $81.19B | $2.98B | $3.45B |
| 2009 | $87.14B | $3.82B | $4.89B |
| 2010 | $94.16B | $4.63B | $5.4B |
| 2011 | $101.86B | $5.14B | $5.95B |
| 2012 | $110.62B | $5.53B | $6.09B |
| 2013 | $122.49B | $5.63B | $5.83B |
| 2014 | $130.47B | $5.62B | $6.6B |
| 2015 | $157.11B | $5.81B | $8.18B |
| 2016 | $184.84B | $7.02B | $8.09B |
| 2017 | $201.16B | $10.56B | $11.57B |
| 2018 | $226.25B | $11.99B | $13.65B |
| 2019 | $242.16B | $13.84B | $16.39B |
| 2020 | $257.14B | $15.4B | $20.12B |
| 2021 | $287.6B | $17.29B | $19.89B |
| 2022 | $324.16B | $20.12B | $23.4B |
| 2023 | $371.62B | $22.38B | $25.68B |
| 2024 | $400.28B | $14.41B | $20.71B |
| 2025 | $447.57B | $12.06B | $16.08B |
Revenue by segment
How UnitedHealth Group Incorporated makes its money and how that has shifted. Names are as the company reports them.
- Premiums$352.2B79%
- Products$53.4B12%
- Services$38.0B8%
The company split earlier years differently. A history would not be comparable, so only 2025 is shown.
Figures as a table
| 2025 | Share 2025 | |
|---|---|---|
| Premiums | $352.23B | 78.7% |
| Products | $53.38B | 11.9% |
| Services | $38.04B | 8.5% |
| Total revenue | $447.57B | 100% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 20 Oct 2026)
- Valuation signal Undervalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.